Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Tang, B; Li, Y; Nagaraj, C; Morty, RE; Gabor, S; Stacher, E; Voswinckel, R; Weissmann, N; Leithner, K; Olschewski, H; Olschewski, A.
Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells.
Am J Respir Cell Mol Biol. 2009; 41(4): 476-483.
Doi: 10.1165/rcmb.2008-0412OC
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-authors Med Uni Graz
-
Chandran Nagaraj
-
Gabor Sabine
-
Leithner Katharina
-
Li Yingji
-
Olschewski Andrea
-
Olschewski Horst
-
Stacher-Priehse Elvira
-
Tang Bi
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Endothelin (ET)-1 causes long-lasting vasoconstriction and vascular remodeling by interacting with specific G-protein-coupled receptors in pulmonary artery smooth muscle cells (PASMCs), and thus plays an important role in the pathophysiology of pulmonary arterial hypertension. The two-pore domain K(+) channel, TASK-1, controls the resting membrane potential in human PASMCs (hPASMCs), and renders these cells sensitive to a variety of vasoactive factors, as previously shown. ET-1 may exert its vasoconstrictive effects in part by targeting TASK-1. To clarify this, we analyzed the ET-1 signaling pathway related to TASK-1 in primary hPASMCs. We employed the whole-cell patch-clamp technique combined with TASK-1 small interfering RNA (siRNA) in hPASMC and the isolated, perfused, and ventilated mouse lung model. We found that ET-1 depolarized primary hPASMCs by phosphorylating TASK-1 at clinically relevant concentrations. The ET sensitivity of TASK-1 required ET(A) receptors, phospholipase C, phosphatidylinositol 4,5-biphosphate, diacylglycerol, and protein kinase C in primary hPASMCs. The ET-1 effect on membrane potential and TASK-1 was abrogated using TASK-1 siRNA. This is the first time that the background K(+) channel, TASK-1, has been identified in the ET-1-mediated depolarization in native hPASMC, and might represent a novel pathologic mechanism related to pulmonary arterial hypertension.
- Find related publications in this database (using NLM MeSH Indexing)
-
Animals -
-
Arachidonic Acids - pharmacology
-
Drug Synergism -
-
Endothelin-1 - pharmacology
-
Humans -
-
Lung - blood supply
-
Membrane Potentials - drug effects
-
Mice -
-
Mice, Inbred C57BL -
-
Myocytes, Smooth Muscle - drug effects
-
Nerve Tissue Proteins - antagonists and inhibitors
-
Patch-Clamp Techniques -
-
Perfusion -
-
Phosphorylation - drug effects
-
Polyunsaturated Alkamides - pharmacology
-
Potassium - metabolism
-
Potassium Channels, Tandem Pore Domain - antagonists and inhibitors
-
Pressure -
-
Protein Processing, Post-Translational - drug effects
-
Pulmonary Artery - cytology
-
Signal Transduction - drug effects
-
Vasoconstriction - drug effects
- Find related publications in this database (Keywords)
-
endothelin-1
-
TASK-1 channel
-
membrane potential
-
pulmonary hypertension